You have 9 free searches left this month | for more free features.

low-dose radiotherapy

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Extracranial Malignant Solid Tumor, Radiotherapy, Immune Checkpoint Blockade Trial in Shantou (Intestinal Low Dose

Not yet recruiting
  • Metastatic Extracranial Malignant Solid Neoplasm
  • +3 more
  • Intestinal Low Dose Radiotherapy-1Gy
  • +3 more
  • Shantou, Guangdong, China
    Cancer Hospital, Shantou University Medical College
Oct 7, 2023

Colorectal Liver Metastases Trial in Nanjing (Radiation: High- and Low-dose radiotherapy, PD-1 Inhibitors)

Recruiting
  • Colorectal Liver Metastases
  • Radiation: High- and Low-dose radiotherapy
  • PD-1 Inhibitors
  • Nanjing, Jiangsu, China
    Jiangsu Cancer Hospital
Sep 13, 2023

Cancer Patients Trial in Jinan (Low-dose radiotherapy combined with conventional fractionated radiotherapy)

Recruiting
  • Cancer Patients
  • Low-dose radiotherapy combined with conventional fractionated radiotherapy
  • Jinan, In Shandong Province, China
    The First Affiliated Hospital of Shandong First Medical Universi
Jun 7, 2023

NSCLC Trial (KB-GDT-01)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • KB-GDT-01
  • (no location specified)
Sep 29, 2023

Microsatellite Stable Metastatic Colorectal Cancer Trial in Shanghai (Regorafenib, Toripalimab, High/low-dose radiotherapy)

Recruiting
  • Microsatellite Stable Metastatic Colorectal Cancer
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 19, 2023

Metastatic Cancer Trial in Nanchang (High- and Low-dose radiotherapy)

Recruiting
  • Metastatic Cancer
  • High- and Low-dose radiotherapy
  • Nanchang, Jiangxi, China
  • +1 more
Mar 6, 2023

Pancreatic Cancer Trial in Modena (LDR, Gem-based doublets, SBRT)

Recruiting
  • Pancreatic Cancer
  • LDR
  • +2 more
  • Modena, MO, Italy
    Azienda Ospedaliero-Universitaria Policlinico di Modena
Dec 8, 2022

Arthrosis, Osteoarthritis Trial (low dose radiotherapy (0.5 Gy), mock radiation treatment, low dose radiotherapy (1.0 Gy))

Not yet recruiting
  • Arthrosis
  • Osteoarthritis
  • low dose radiotherapy (0.5 Gy)
  • +2 more
  • (no location specified)
May 31, 2023

Indolent Lymphoma, Low-dose Radiotherapy Trial in Beijing (Low-dose radiotherapy)

Recruiting
  • Indolent Lymphoma
  • Low-dose Radiotherapy
  • Low-dose radiotherapy
  • Beijing, Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Sep 13, 2022

NSCLC, Low Dose Radiotherapy, Stereotactic Body Radiotherapy Trial in Chengdu (Low Dose Radiotherapy, stereotactic body

Not yet recruiting
  • NSCLC
  • +3 more
  • Low Dose Radiotherapy
  • +2 more
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Nov 11, 2022

Tumors, Secondary Malignant Tumor Trial (SBRT + LDRT, SBRT alone)

Not yet recruiting
  • Neoplasms
  • Secondary Malignant Neoplasm
  • SBRT + LDRT
  • SBRT alone
  • (no location specified)
Nov 15, 2022

Tumors, Secondary Malignant Tumor Trial in Seoul (SBRT + LDRT)

Recruiting
  • Neoplasms
  • Secondary Malignant Neoplasm
  • SBRT + LDRT
  • Seoul, Korea, Republic of
  • +1 more
Feb 16, 2023

Covid19 Trial in Preston (Low dose Radiotherapy)

Completed
  • Covid19
  • Low dose Radiotherapy
  • Preston, United Kingdom
    Lancashire Teaching Hospitals NHS
Nov 9, 2022

Non Hodgkin Lymphoma Trial in Philadelphia (Pembrolizumab)

Recruiting
  • Non Hodgkin Lymphoma
  • Philadelphia, Pennsylvania
    Abamson Cancer Center of the University of Pennsylvania
Jan 9, 2023

Squamous Cell Carcinoma of Oral Cavity, Pharynx Carcinoma, Larynx Carcinoma Trial in Gliwice (Chemotherapy

Recruiting
  • Squamous Cell Carcinoma of Oral Cavity
  • +3 more
  • Chemotherapy (carboplatin+paclitaxel) with concomitant low dose ionizing radiotherapy
  • Gliwice, Silesia, Poland
    The Maria Sklodowska-Curie National Research Institute of Oncolo
Aug 7, 2023

Locally Advanced Nasopharyngeal Carcinoma Trial in Sichuan (low-dose radiotherapy)

Recruiting
  • Locally Advanced Nasopharyngeal Carcinoma
  • low-dose radiotherapy
  • Sichuan, Sichuan, China
    Low-dose Radiotherapy and Neoadjuvant Chemotherapy Sequential Co
Aug 16, 2022

Nasopharyngeal Carcinoma, Immune Checkpoint Inhibitor, Radiotherapy Trial (radiation, drug, biological)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • +3 more
  • Intensity Modulated Radiation Therapy
  • +3 more
  • (no location specified)
Jul 11, 2023

Cancer Patients Trial in Jinan (At the same time, the original regimen of immunomaintenance therapy was continued, according to

Recruiting
  • Cancer Patients
  • At the same time, the original regimen of immunomaintenance therapy was continued, according to the frequency of the original immunization regimen once every 3 weeks until progress.
  • Jinan, In Shandong Province, China
    The First Affiliated Hospital of Shandong First Medical Universi
Sep 16, 2022

Head and Neck Squamous Cell Carcinoma, Neoadjuvant Treatment Trial in Zhuhai (Tislelizumab, Low-dose radiotherapy)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Neoadjuvant Treatment
  • Zhuhai, Guangdong, China
    Fifth Affilliated Hospital of Sun Yat-sen University
Apr 22, 2022

Hodgkin Lymphoma Trial in Philadelphia (Nivolumab)

Terminated
  • Hodgkin Lymphoma
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
May 20, 2022

Objective Response Rate Trial in Wuhan (GM-CSF)

Recruiting
  • Objective Response Rate
  • Wuhan, Hubei, China
    Renmin Hospital of Wuhan University
Feb 25, 2023

Nasopharyngeal Carcinoma Trial (low-dose radiotherapy)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • low-dose radiotherapy
  • (no location specified)
Mar 22, 2022

Extensive-stage Small-cell Lung Cancer Trial in China (serplulimab, Cisplatin, Carboplatin)

Not yet recruiting
  • Extensive-stage Small-cell Lung Cancer
  • Shantou, Guangdong, China
  • +6 more
Mar 1, 2023

Hidradenitis Suppurativa, Hidradenitis Trial in Bronx (Low dose Radiotherapy)

Terminated
  • Hidradenitis Suppurativa
  • Hidradenitis
  • Low dose Radiotherapy
  • Bronx, New York
    Montefiore Medical Center
Oct 20, 2021

Lung Cancer, Extensive-stage Small-cell Lung Cancer, Durvalumab Trial in Chongqing, Zhengzhou, Chengdu (Low-dose radiotherapy,

Recruiting
  • Lung Cancer
  • +2 more
  • Low-dose radiotherapy
  • +2 more
  • Chongqing, Chongqing, China
  • +2 more
May 4, 2022